FOXM1 is now used in the clinic as a prognostic and predictive marker for stage and grade of bladder cancer [42], and has been identified as the most significant prognostic factor for overall survival in patients with hepatocellular carcinoma [40, 41]. Here, FOXM1 is linked to hepatocellular carcinoma.